Melodiol Global Health Ltd News

Melodiol Global's Mernova Unit Launches More Products; Shares Jump 50%

Cannabis-focused company Melodiol Global Health's (ASX:ME1) shares surged 50% on Thursday following the launch of several products by its Canadian subsidiary Mernova, as well as new purchase orders. M

MT NewswiresMay 9 00:31 ET

Melodiol Global Health Subsidiary Health House Australia to Launch Medicinal Cannabis Clinic

Melodiol Global Health (ASX:ME1), through its subsidiary Health House Australia, is set to launch its medicinal cannabis clinic called the Health House Wellness Clinic in the second quarter of 2024, a

MT NewswiresApr 8 21:28 ET

Melodiol Global Health Posts 148% Increase in FY 2023 Revenue to AU$21.6 Million

Melodiol Global Health (ASX:ME1) has posted unaudited revenues of AU$3.1 million through February and ongoing total unaudited group revenue from all operations of AU$21.6 million in the 2023 financial

MT NewswiresMar 26 18:02 ET

Melodiol Unit to Add Cannabis Products Across Six Canadian Provinces

Melodiol Global Health's (ASX:ME1) Canadian subsidiary Mernova Medicinal reached agreements with six provincial governments in Canada to add more cannabis-related products during the first fiscal quar

MT NewswiresFeb 13 02:32 ET

Melodial's Unit Logs AU$1 Million Revenues in January

Melodiol Global Health (ASX:ME1) said its unit Health House International reported a revenue of AU$1 million in January. The revenue was generated from the medicinal cannabis company's established Aus

MT NewswiresFeb 7 00:56 ET

Melodiol Global's Canadian Arm Mernova Posts Record Sales for October

Melodiol Global Health (ASX:ME1) said Canadian subsidiary Mernova Medicinal has secured several purchase orders to "underpin" fiscal fourth-quarter revenue. The firm also said that the unit logged rec

MT NewswiresNov 2, 2023 08:56 ET

Melodiol Global Health Achieves 80% Remission Rate From Phase Two Hallucinogenic Trial

Melodiol Global Health (ASX:ME1) achieved an 80% remission rate from the first five patients treated in its phase two trial investigating the efficacy of the medical cannabis firm's Lucenex medication

MT NewswiresOct 11, 2023 22:04 ET

Melodial's Canadian Arm Mernova Logs Record Sales in Q3

Melodial Global Health (ASX:ME1) said Canadian subsidiary Mernova Medicinal logged its third consecutive quarter of growth during the three-month period ended Sep. 30, and logged a record revenue of r

MT NewswiresOct 10, 2023 08:58 ET

Melodiol Logs Strong Start to Q3 With AU$1.6 Million in Revenue and Confirmed Purchase Orders

Melodiol Global Health (ASX:ME1) is seeing a strong start to the third quarter of 2023 as it has already booked AU$1.6 million in new unaudited revenue and confirmed purchase orders as of July 17. The

MT NewswiresJul 20, 2023 08:27 ET

Melodiol Global Health Triples Q2 Net Sales

Melodiol Global Health (ASX:ME1) reported a 202% year over year jump in second-quarter net sales to AU$4.7 million. The results were highlighted by strong growth across subsidiaries specialist medicin

MT NewswiresJul 13, 2023 02:25 ET